Knee ArthritisCOLRASNCT05509972
In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
An observational study of Knee Arthritis and Knee Osteoarthritis, run by Aesculap AG at 1 site in Germany.
Trial summary
This clinical study is a Post-Market Clinical Follow-Up (PMCF) measure and is aiming to compare the in-vivo wear behaviour of the Columbus® total knee prosthesis between the standard Cobalt Chromium (CoCr) and the multilayer coated so called "Advanced Surface" (AS) of the same implant. Read more about this study
- Who is it for?
- Ages 45 to 75 years
- Conditions the study is for
- Knee Arthritis, Knee Osteoarthritis, Primary Osteoarthritis of Knee Nos
- What is being tested?
- total knee prosthesis implantation
- Type of treatment
- Medical device
- How many people
- 7 participants
- Where
- 1 siteGermany
- Study dates
- 6 Apr 2023to 30 Aug 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients will be recruited consecutively.
Who may be able to join
- Indication for a primary bicondylar total knee endoprosthesis with the Columbus® DD knee prosthesis
- Written signed informed consent of patient
- Willingness and mental ability to participate at the long-term follow-up examinations
Who cannot join
- Pregnancy
- Patient age <45 and >75years
- Acute inflammatory arthritis
- Coagulation disorders (e.g. Haemophilia)
Trial locations and contacts
1 site in 1 country.
Germany1 site
Universitätsklinik Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, 79106
About this study
Official title: International, Prospective, Longterm Study Comparing the Clinical Outcome and In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
This clinical study is a Post-Market Clinical Follow-Up (PMCF) measure and is aiming to compare the in-vivo wear behaviour of the Columbus® total knee prosthesis between the standard Cobalt Chromium (CoCr) and the multilayer coated so called "Advanced Surface" (AS) of the same implant. The clinical investigation is designed as a International, prospective, longterm non-interventional study in order to gain clinical data of many patients within the routine clinical application of the investigational device.
- Conditions
- Knee Arthritis, Knee Osteoarthritis, Primary Osteoarthritis of Knee Nos, Secondary Osteoarthritis of Knee Nos, Rheumatoid Arthritis of Knee, Instability, Joint
- Being tested
- total knee prosthesis implantation
- Keywords
- Total Knee Arthroplasty, Implant Wear, Advanced Surface
- Medical subject headings
- Osteoarthritis, Knee, Joint Instability, Osteonecrosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
total knee prosthesis implantationDevice
Also called Columbus® Total Knee Arthroplasty
Total Knee Arthroplasty (TKA) represents a well-established, reliable and successful treatment option for end-stage bicompartmental osteoarthritis or comparable conditions even in young patients compromised by knee pain and limitations of daily living
| Study group | Role | What they receive |
|---|---|---|
| Columbus® DD Primary CoCr | Columbus® Deep Dish (DD) Primary Cobalt Chromium (CoCr) Receives: Device: total knee prosthesis implantation | |
| Columbus® DD Primary CoCr AS coated | Columbus® Deep Dish (DD) Primary Cobalt Chromium (CoCr) Advanced Surface Receives: Device: total knee prosthesis implantation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Polyethylene wear over time
The in-vivo wear of the Polyethylene (PE) tibial tray will be assessed using the observer independent method of the imaging core lab. The PE wear assessment is based on the absolute object position of the knee prosthesis over time.
Measured: until 10 years postoperatively
Secondary outcomes (11)
Implant survival
Kaplan-Meier Analysis is a standard statistical method to describe the survival of human subjects or medical products over a defined time period.
Measured: until 10 years postoperatively
Quality of Life [EQ-5D-5L] compared to baseline
The 5-dimension 5-level measure of the health status, developed by the EuroQol Group (EQ-5D-5L) is a simple and generic measure for clinical and economic assessment. Instructions for the user are directly included into the questionnaire and it consists of two pages. One cover five different dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression) and the other one the EQ visual Analogue Scale (EQ-VAS). The VAS scale records the self rated health status of the patient from the level "the worst health you can imagine" to "the best health you can imagine".
The answer of each of the five dimensions result in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
Measured: preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Progress of Clinical Outcome (Forgotten Joint Score-12) over follow-up period
The Forgotten Joint Score-12 (FJS-12) Knee was designed to assess patient outcome in patients undergoing conservative or operative treatment of the knee. These Patient Reported Outcome (PRO) questionnaires focus on patients' awareness of a specific joint in everyday life. In 12 Items the awareness for the artificial joint is assessed by the patient, each on a five point scale (Never / Almost Never / Seldom / Sometimes / Mostly) The Forgotten Joint Score assessment consists of 12 questions and is scored on a 0-100 scale. The higher the score, the less the patient is aware of their affected joint when performing daily activities
Measured: 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Progress of Clinical Outcome [Oxford Knee Score] compared to baseline
The Oxford Knee Score (OKS) is a reliable 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing total knee replacement. It is short, reproducible, valid and sensitive to clinically important changes over time. Each of the 12 questions on the OKS is scored in the same way with the score decreasing as the reported symptoms increase (i.e. become worse). All questions are laid out with response categories denoting least (or no) symptoms to the left of the page (scoring 4) and those representing greatest severity lying on the right hand side (scoring 0), as detailed for question 1 below. This method, when summed, produces overall scores running from 0 to 48 with 48 being the best outcome,
Measured: preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Radiographic comparison of alignment over time
Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. The radiographic evaluation of Alignment combines Hip-Knee-Angle, femoral and tibial component alignment
Measured: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographic comparison of implant migration over time
Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. The radiographic evaluation of implant migration comprises tibial and femoral components in m/l and a/p direction,
Measured: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographic comparison of tibial slope over time
Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. Any changes of Tibial slope over the follow-up period is documented in the radiographic evaluation
Measured: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographic comparison of the joint line over time
Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine. Any changes of the joint line over the follow-up period is documented in the radiographic evaluation
Measured: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Adverse events / serious adverse events
During the course of the study, any upcoming intra- or postoperative (serious) adverse events (AE / SAE) or device effects related or not related to the product under investigation or the procedure, will be documented in the dedicated Case Report Forms. The total number of AEs will be summarized and further evaluated by the sponsor and reported according to local legislation and necessity. Recorded complications will be categorized and analyzed in order to assess the safety of the investigational product
Measured: During the course of the study up to 10 years postoperatively
Number of Participants with radiological complications over time
Radiographs shall be standardized between centres as far as possible. Unless limited by patient or equipment constraints, all follow-up imaging examinations will be obtained according to the radiographic protocol of the hospital and the set routine.
All radiologically evident complications (including fracture, wear, loosening or radiolucencies) are cumulatively documented over the period of follow-up.
Measured: During the course of the study up to 10 years postoperatively
Biomechanical analysis of retrievals in case of revision
Available retrievals of explanted investigational products will be analysed by the biomechanical laboratory of the sponsor according to an analysis protocol which includes the oxidation profile, the wear behaviour, the mechanics and the cumulative linear abrasion of these retrievals.
Measured: During the course of the study up to 10 years postoperatively
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Aug 2022
- Study start6 Apr 2023
- Primary completion1 Feb 2024
- Study completion30 Aug 2024
Why it stopped: Recruitment too slow
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Knee ArthritisStudies of the same condition, open and under way.
- More trials run by Aesculap AGThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 7 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aesculap AG
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Raylytic GmbH
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05509972
- Sponsor's protocol ID
- AAG-O-H-2024
- Acronym
- COLRAS
- Status last verified
- Oct 2024
- First submitted
- 11 Aug 2022
- Last updated
- 9 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- International, Prospective, Longterm Study Comparing the Clinical Outcome and In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
- ClinicalTrials.gov ID
- NCT05509972
- Acronym / sponsor ID
- COLRAS / AAG-O-H-2024
- Conditions
- Knee Arthritis, Knee Osteoarthritis, Primary Osteoarthritis of Knee Nos, Secondary Osteoarthritis of Knee Nos, Rheumatoid Arthritis of Knee, Instability, Joint
- Keywords
- Total Knee Arthroplasty, Implant Wear, Advanced Surface
- Study type
- Observational
- Recruitment status
- TerminatedReason stopped: Recruitment too slow
- Enrolment
- 7 participants (actual)
- Lead sponsor
- Aesculap AGIndustry (pharma, biotech, devices)
- Collaborators
- Raylytic GmbH
- Study start
- 6 Apr 2023 (actual)
- Primary completion
- 1 Feb 2024 (actual)
- Study completion
- 30 Aug 2024 (actual)
- First posted
- 22 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This clinical study is a Post-Market Clinical Follow-Up (PMCF) measure and is aiming to compare the in-vivo wear behaviour of the Columbus® total knee prosthesis between the standard Cobalt Chromium (CoCr) and the multilayer coated so called "Advanced Surface" (AS) of the same implant. The clinical investigation is designed as a International, prospective, longterm non-interventional study in order to gain clinical data of many patients within the routine clinical application of the investigational device.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Columbus® DD Primary CoCr | – | Device: total knee prosthesis implantationColumbus® Deep Dish (DD) Primary Cobalt Chromium (CoCr) |
| Columbus® DD Primary CoCr AS coated | – | Device: total knee prosthesis implantationColumbus® Deep Dish (DD) Primary Cobalt Chromium (CoCr) Advanced Surface |
Who may qualify
- Ages
- 45 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients will be recruited consecutively.
Key inclusion criteria (3 listed)
- Indication for a primary bicondylar total knee endoprosthesis with the Columbus® DD knee prosthesis
- Written signed informed consent of patient
- Willingness and mental ability to participate at the long-term follow-up examinations
Key exclusion criteria (4 listed)
- Pregnancy
- Patient age <45 and >75years
- Acute inflammatory arthritis
- Coagulation disorders (e.g. Haemophilia)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| total knee prosthesis implantationAlso: Columbus® Total Knee ArthroplastyTotal Knee Arthroplasty (TKA) represents a well-established, reliable and successful treatment option for end-stage bicompartmental osteoarthritis or comparable conditions even in young patients compromised by knee pain and limitations of daily living | Device | Columbus® DD Primary CoCr, Columbus® DD Primary CoCr AS coated |
Primary outcome
Polyethylene wear over time
Time frame: until 10 years postoperatively
The in-vivo wear of the Polyethylene (PE) tibial tray will be assessed using the observer independent method of the imaging core lab. The PE wear assessment is based on the absolute object position of the knee prosthesis over time.
11 secondary outcomes
Implant survival
Time frame: until 10 years postoperatively
Quality of Life [EQ-5D-5L] compared to baseline
Time frame: preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Progress of Clinical Outcome (Forgotten Joint Score-12) over follow-up period
Time frame: 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Progress of Clinical Outcome [Oxford Knee Score] compared to baseline
Time frame: preoperatively and 3 months, 12 months, 2 years, 5 years, 10 years postoperatively
Radiographic comparison of alignment over time
Time frame: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographic comparison of implant migration over time
Time frame: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographic comparison of tibial slope over time
Time frame: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Radiographic comparison of the joint line over time
Time frame: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years
Adverse events / serious adverse events
Time frame: During the course of the study up to 10 years postoperatively
Number of Participants with radiological complications over time
Time frame: During the course of the study up to 10 years postoperatively
Biomechanical analysis of retrievals in case of revision
Time frame: During the course of the study up to 10 years postoperatively
Results and safety
The study was stopped early (reason given: Recruitment too slow). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2024.
Related trials for Knee Arthritis
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
RecruitingObservational study
Exploring Factors Linked to Worsening Over Time in People With Early-stage Knee Osteoarthritis and Those With Prior Proven Acute Knee Injury.
Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Knee Arthritis and Knee Osteoarthritis, run by Aesculap AG at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 9 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Recruitment too slow). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Polyethylene wear over time (time frame: until 10 years postoperatively). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2024.